Insider filing · KYMR
Jared Gollob
Chief Medical Officer
profile →
Kymera Therapeutics, Inc.
KYMR · Healthcare · 59 filings in 24 months
ticker →
Jared Gollob sold $4.4M of Kymera Therapeutics (KYMR)
Executed Dec 8 2025, disclosed Dec 8 2025, the same day.
Value, as filed
$4.4M
49,307 sh across 6 lots
Executed
Dec 8 2025
the trade date, as filed
Disclosed
Dec 8 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JGJared Gollob (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $4.4M of KYMR (49,307 sh across 6 lots, as filed), executed Dec 8 2025.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jared Gollob in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$743K8,514 sh across 4 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $3.7M
59,576 sh across 4 lots
Exec Oct 15 2025
Filed Oct 15 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $187K
3,114 sh × $60.00
Exec Oct 13 2025
Filed Oct 14 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $142K
4,695 sh × $30.33
Exec Mar 3 2025
Filed Mar 3 2025 · 5:30 PM ET